sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
ugaauacugucccuuuuaagcaa | 688 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 688 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 691 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 691 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 670 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 670 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 732 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 732 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 729 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 729 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 728 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 728 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 689 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 689 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 669 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 669 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 23 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 23 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 745 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 745 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 15 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 15 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 686 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 686 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 692 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 692 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 685 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 685 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 746 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 746 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 731 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 731 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 704 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 704 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 666 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 666 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 663 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 663 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 702 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 702 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 664 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 664 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugagaacauacuuuccccuuaaa | 311 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugagaacauacuuuccccuuaaa | 311 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugagaacauacuuuccccuuaaa | 621 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugagaacauacuuuccccuuaaa | 621 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uguccagcuuuauugggaggcca | 230 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uguccagcuuuauugggaggcca | 230 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uguccagcuuuauugggaggcca | 592 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uguccagcuuuauugggaggcca | 592 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucccaauaaagcuggacaaga | 716 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucccaauaaagcuggacaaga | 716 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
auugaacaguauauuucagga | 1999 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
auugaacaguauauuucagga | 1999 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
auugaacaguauauuucagga | 3064 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
auugaacaguauauuucagga | 3064 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 306 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 306 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 486 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 486 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 36 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 36 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 756 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 756 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacauuacucaugaauacau | 3528 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacauuacucaugaauacau | 3528 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacauuacucaugaauacau | 2463 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaucacauuacucaugaauacau | 2463 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acuacuacagagugcuaagcugc | 2694 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acuacuacagagugcuaagcugc | 2694 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugguuaccauagaaacuuccuuu | 2692 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugguuaccauagaaacuuccuuu | 2692 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugguuaccauagaaacuuccuuu | 2825 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugguuaccauagaaacuuccuuu | 2825 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucaaaccacacauuagauuguuc | 2397 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucaaaccacacauuagauuguuc | 2397 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucaaaccacacauuagauuguuc | 3462 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ucaaaccacacauuagauuguuc | 3462 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1644 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1644 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1423 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1423 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1680 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1680 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1387 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1387 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agugaggcuuaugaaaugcca | 971 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agugaggcuuaugaaaugcca | 971 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agugaggcuuaugaaaugcca | 1245 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agugaggcuuaugaaaugcca | 1245 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacgacagugugguguaaaggaa | 2537 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacgacagugugguguaaaggaa | 2537 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acagagugcuaagcugcaugugu | 2695 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acagagugcuaagcugcaugugu | 2695 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acauucucccaaguuauucagcc | 2843 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acauucucccaaguuauucagcc | 2843 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acauucucccaaguuauucagcc | 2740 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acauucucccaaguuauucagcc | 2740 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uauaaacugcuagcaugucuaga | 615 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uauaaacugcuagcaugucuaga | 615 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.